Results 91 to 100 of about 82,500 (201)

Precautions for polygenic embryo selection: prohibition or cautious use. [PDF]

Front Reprod Health
Ishii T.
europepmc   +1 more source

Histocompatibility Testing, 1975 [PDF]

British Journal of Cancer, 1976
openaire   +1 more source

A new path to spillover: MHC-II entry of influenza A viruses. [PDF]

PLoS Biol
Stertz S, Karakus U.
europepmc   +1 more source

Non-HLA Genetics and Application to Living Donor Candidates. [PDF]

Curr Transplant Rep
Caliskan Y, Afsar B, Afsar RE, Varma C, Aygormez O, Lentine KL.   +5 more
europepmc   +1 more source

T-cell receptor insights: Determinants of Major Histocompatibility Complex class I versus class II recognition. [PDF]

Protein Sci
De Almeida Mendes M, Chihab L, Nilsson JB, Scheffer L, Nielsen M, Peters B.   +5 more
europepmc   +1 more source

Case Report: A novel CIITA mutation causing MHC class II deficiency: first reported case in Morocco. [PDF]

Front Immunol
Kattra AB, Ailal F, Benhsaien I, Fahi M, Drissi Bourhanbour A, Elamine A, Aadam Z, Errami A, Bousfiha AA, El Bakkouri J.   +9 more
europepmc   +1 more source

Milestones in Transplantation: The Story so Far [PDF]

, 2001
Starzl, TE
core  

Clustering-based identification of immune-related gene signatures in hepatocellular carcinoma. [PDF]

Ecancermedicalscience
Brahmaiah J, Adiga U, Augustine AJ, Vasishta S.   +3 more
europepmc   +1 more source

AlloPipe and Its Web Server Allogenomics: From Genomic Data to Candidate Minor Histocompatibility Antigens. [PDF]

HLA
Dhuyser A, Delaugère P, Laville P, Clerc R, Aarnink A, Mesnard L, Richard H.   +6 more
europepmc   +1 more source

Engineering systemic oncolytic virotherapy through immune-compatible delivery and programmable tumor cell death. [PDF]

Mol Ther Oncol
Chen X, Chen Y, Ping Y.
europepmc   +1 more source